Efficacy of botulinum toxin in pediatric spasticity: a randomized trial comparing 2- to 4- sites hamstring injectio

Phase 4

Recruiting

• Conditions: Spastic Cerebral palsy; Cerebral palsy; Muscle Spasticity; Botulinum Toxins

• Registration Number: TCTR20150803003
• Lead Sponsor: Thammasat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-08-03
• Study Completion: 2017-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Cerebral palsy children who have spasticity Modified Ashworth Scale-Bohannon (MAS-B) score 1+, 2 and 3 in Hamstring muscles

Exclusion Criteria

1. surgery or accident in lower extremities muscles before.
2. injected with Botulinum toxin six months before joining the study.
3. allergic to the components of the Botulinum toxin.
4. have Neuromuscular disease such as Myasthenia gravis and Eaton Lambert syndrome or on the medication that affects the use of botulinum toxin.
5. have an easily bleeding tendency disease or on an anti-blood clotting medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified